Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada-Reference-Cited by-同舟云学术

Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada

Published:2018-05 Issue: Volume:Volume 14 Page:81-89
ISSN:1178-2048
Container-title:Vascular Health and Risk Management
language:en
Short-container-title:VHRM

Author:

Senay Andréa,Trottier Milanne,Delisle Josée,Banica Andreea,Benoit Benoit,Laflamme G Yves,Malo Michel,Nguyen Hai,Ranger Pierre,Fernandes Julio C

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Public Health, Environmental and Occupational Health,Hematology,General Medicine,Endocrinology, Diabetes and Metabolism

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying pulmonary embolism - high risk patients after total knee replacement: systematic review;Journal of the Pakistan Medical Association;2024-07-07

2. Comparison of efficacy of nadroparin and fondaparinux sodium for prevention of deep vein thromboembolism in lower extremities after total hip arthroplasty and total knee arthroplasty: a retrospective study of 592 patients;BMC Surgery;2024-05-18

3. Comparison of Efficacy of Nadroparin and Fondaparinux sodium for Prevention of Deep Vein Thromboembolism in lower extremities after Total Hip Arthroplasty and Total Knee Arthroplasty: a retrospective study of 592 patients;2024-01-03

4. Venous thromboembolism in orthopedic surgery: Global guidelines;Acta Orthopaedica et Traumatologica Turcica;2023-10-27

5. The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the Venous thromboembolism risk after total knee arthroplasty;2023-08-29